| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sr. V.p., Regulatory Affairs
1 company
Martin Tami Tillotson is a Sr. V.p., Regulatory Affairs at SUPERNUS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $3.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Sr. V.p., Regulatory Affairs | Sale+OE | 8,000 | $27.91 | $223,280.00 | -8.5% | +12.8% | +33.2% | |
| Aug 30, 2023 | SUPN Supernus Pharmaceuticals, Inc. | Sr. V.p., Regulatory Affairs | Sale+OE | 8,100 | $32.00 | $259,200.00 | -8.7% | -15.6% | +9.5% | |
| Aug 25, 2023 | SUPN Supernus Pharmaceuticals, Inc. | Sr. V.p., Regulatory Affairs | Sell | 5,135 | $31.59 | $162,214.65 | -5.7% | -11.3% | +11.4% | |
| Aug 22, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Sr. V.p., Regulatory Affairs | Sale+OE | 5,000 | $35.98 | $179,900.00 | -5.4% | -1.9% | -9.5% | |
| Aug 4, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Sr. V.p., Regulatory Affairs | Sale+OE | 5,000 | $32.98 | $164,900.00 | -5.4% | +4.7% | -1.9% | |
| Apr 14, 2021 | SUPN Supernus Pharmaceuticals, Inc. | Sr. V.p., Regulatory Affairs | Sale+OE | 6,250 | $30.98 | $193,639.38 | -3.5% | -12.6% | -2.4% |